Three new employees appointed

27th July 2010 – Today, Oval Medical is pleased to announce that the on-going success of developing its revolutionary autoinjector and syringe technologies, has lead to the company’s second expansion less than a year after the company was established.</p> As of July 2010, three new members have joined the team adopting a variety of roles […]

Continue Reading

Oval Medical signs a technology assessment contract with a pharmaceutical partner

February 12th, 2013 – Oval Medical Technologies Ltd.(“Oval”),  announces that it has signed a further technology assessment contract with a pharmaceutical partner. The drug under investigation is for the treatment of severe infections in patients with chronic lung disease and is expected to be self-injected in a clinical or home setting. The agreement includes a […]

Continue Reading